To observe the effect of a Xixin decoction on learning and memory in APP/PS1 transgenic mice in addition to hippocampal ultrastructure and hippocampal Aβ42 related regulatory enzymes.
Introduction
Alzheimer's Disease (AD) is a neurodegenerative disease that has an insidious onset and slow progression [1] . Despite the vast amount of work done on AD, its pathogenesis is still unclear, resulting in a lack of specific treatments. This deficit is currently a large focus for both Traditional Chinese Medicine (TCM) as well as Western medical research. Although a clear mechanism for AD is still missing, the current "Aβ cascade" theory is a core component of current thinking regarding AD pathogenesis [2] . One school of thought holds that β-amyloid (Aβ) aggregation is a key mechanism in AD pathogenesis, with Aβ accumulation and deposition in the brain being one of the main pathological chang- by the continuous action of β-protease and γ-protease decomposition [4] . As a result, Aβ 42 becomes a key factor in the amyloid plaque nuclear process. The β-Site Amyloid Precursor Protein-Cleaving Enzyme 1 (BACE1) has been recognized as playing a major role in β-secretase activities, as it hydrolyzes amyloid digestion to produce Aβ 42 [5] . To this end, Insulin-Degrading Enzyme (IDE) can reduce the balance of Aβ levels, thereby reducing Aβ aggregation [6] , which can regulate brain Aβ production and clearance. To this end, the work presented here sought to explore the effect of Xixin decoction on the learning and memory abilities of APP/PS1 double transgenic mice as well as hippocampal ultrastructure and brain levels of Aβ 42 . We also sought to understand its effect on the expression and regulation BACE and IDE, to explore possible mechanisms and future treatment options for AD.
Materials and Methods

Drugs
The Xixin decoction was composed of ginseng, fushen, spine date seed, pinellia, dried orange peel, medicated leaven, monkshood, Acorus gramineus, and licorice. Preparation of Xixin Decoction using the corresponding proportion of non-boiling granules. The granules used were provided by Pharmaceutical Co., Ltd., Beijing Kang Rentang. Aricept was obtained in tablet form, which was provided by Eisai (China) Pharmaceutical Co., Ltd. (5 mg/tablet, batch number H20050978).
Materials and equipment
General reagents used included glutaraldehyde, paraformaldehyde, chloral hydrate, physiological saline, sucrose, sodium dihydrogen phosphate, anhydrous ethanol, acetone, citric acid sodium, glycine, Protease Inhibitors PMSF, BD skimmed milk powder, and tissue embedding medium. RIPA lysis and extraction buffer was obtained from Xi'an Science and Technology Co., Ltd. All phosphatase and protease inhibitors were obtained from Roche. Western blot reagents and equipment included HRP (ECL) light-emitting liquid (Millpore), 5 × SDS-PAGE loading buffer, SDS gel kit, BCA Protein Quantification Kit, and PVDF membranes. Primary antibodies included: Aβ42 (Cell Signaling, #14974s), BACE (Cell Signaling, #5606S), IDE (Abcam, AB2077), and all were conjugated to a FITC secondary antibody for immunofluorescence using DAPI as a counterstain (for immunofluorescence). General protein localization and quantification reagents also included an anti-quenching agent, 0.3% Tritonx-100, and 10% calf serum. Behavioral testing included the use of a Morris water maze test. In addition, this experiment also involves fluorescence microscope, electrophoresis, transfer membrane apparatus, etc.
Experimental animals and groups
APP/PS1 double transgenic mice (License No. SCXK (Su) 2015-0001) and APP/PS1 C57/B6J negative littermate controls were purchased from the Nanjing Institute of Animal Models. Experimental groups were as follows: Blank Control group (APP/PS1 C57BL/6J negative littermates), Model group (APP/PS1, double transgenic mice), Aricept group (APP/PS1 transgenic mice), and Xixin decoction group (APP/PS1 transgenic mice). All groups included 12 mice each. Animal drug delivery was calculated according to the human and mouse body surface area conversion formula to yield the unit dosage in mice. Dosages were as follows: Xixin decoction group (1.8 g/kg/d) and Aricept group (0.014 mg/kg/d). Both the model control groups received identical saline volumes. Drug administration was conducted using intragastric gavage (i.g.) for all groups and administration occurred daily for three months.
Behavioral tests
After three months' of gastric lavage, all subjects were given the Morris water maze test to assess their learning and memory. The place navigation test was used to measure the spatial learning and memory ability of the animals in the water maze. The animals were allowed to swim freely for 2 min before the test. During the test, the animals were trained twice daily each for 120 s for 5 d. A quadrant adjacent to the quadrant in which the platform is located was selected to put the mice facing the wall into the water and the time for them to find the target platform and climb up was recorded, respectively. This time span was called escape latency. Swimming distance was also recorded for each mice. If the mice did not find the platform in 120 s, it will be brought out of the water to the platform by the experimenter and stays there for 20 s. For such mice the escape latency was recorded as 120 s. Spatial probe test was used to measure the memory ability of mice for memorizing the accurate location of the platform, namely, memory retention. The mice was put into the water from any place to swim for 120 s and the crossing platform times of mice in the target quadrant (the quadrant in which the platform is located) and other quadrants was recorded, respectively.
Transmission Electron Microscopy (TEM)
After the conclusion of behavioral testing, mice were administered an intraperitoneal injection of 10% chloral hydrate aldehyde anesthesia (0.01 ml/g). They were then transcardially perfused, with sufficient exsanguination having occurred when (1) Both the liver and lung had turned white and (2) The right atrium effluent ran clear. We then used 4% polyoxymethylene as a fixative, using a hardened liver as an indicator for successful fixation. The mouse was then rapidly decapitated, brain tissue harvested, and placed in glutaraldehyde for overnight fixation. After fixation, we used an ultramicrotome to cut 70 nm ultrathin sections of hippocampal tissue. We then used a JEM-1230 TEM to observe and image neuronal ultrastructure in murine hippocampal CA1, CA2, and CA3 for later analysis.
Western blot
Mice were decapitated, the hippocampi rapidly dissected, and tissue placed in the -80 °C for preservation. Tissue was lysed using RIPA lysis and extraction buffer, ultrasonically homogenized, and then centrifuged at 4 °C for 10 min at 12,000 rpm. The supernatant was extracted and subjected to protein quantification. Protein was equally loaded into gels, electrophoresed, and transferred onto a PVDF membrane. The resulting blots were then incubated at 4 °C overnight with various primary antibodies. Blots were washed briefly and then incubated with secondary antibody at room temperature for 2 h. Blots were then rinsed, incubated with ECL luminous fluid, and Optical density of each band in the image was an-alyzed via image collecting and analyzing software of digital medical image analysis system.
Immunofluorescence assay
A separate group of mice were rapidly decapitated, whole brain tissue harvested, and fixed in 4% paraformaldehyde overnight. Fixed tissue was then dehydrated by submerging in 30% sucrose at 4 °C overnight. This dehydration step was repeated twice. After dehydration, tissue was placed in a -20 °C cryostat microtome, embedded using OCT embedding medium, and cut into 4 µm sections. Sections were then incubated with various primary antibodies diluted in PBS, 4 °C overnight. Second FITC antibody incubation occurred in the dark at room temperature using an immunofluorescence antibody dilution diluent. Sections were then counterstained with the nuclear DAPI stain for approximately 5-10 min. Solution was discarded and slices were washed twice with PBS containing 0.3% triton-x100 washed (5 min per wash) followed by a final PBS was (5 min). PBS was discarded and an appropriate amount of fluorescent quenching protection liquid was then added. Slices were then mounted on slides and observed using a fluorescence microscope (Olympus 1X71).
Statistical analysis
A commercially available statistical package (SPSS19.0) was used to analyze all data. A single factor, Analysis of Variance (ANOVA) was used to compare data between groups. A p-value less than 0.05 were considered statistically significant.
Results
Behavioral tests
Mice showed a downward trend in average escape latency with training. Starting from Day 3 and when compared with the Model group, the Xixin decoction group had significantly shortened average escape latencies (P < 0.05). There were no significant differences when comparing the Aricept with Xixin decoction groups (P > 0.05). When comparing the Model and control groups, Xixin treated mice showed significantly increased platform crossings (P < 0.05). There were no significant differences in platform crossings between the Aricept and ganelles. Similarly, hippocampal CA2 and CA3 revealed normal cell structure, morphologically normal organelles, and only a small amount of lipofuscin ( Figure 7) .
The Model group revealed degeneration of hippocampal CA1 neurons, the disappearance of organelles, and evidence of mitochondrial injury (e.g. spinal frac-Model groups (P > 0.05) ( Table 1, Table 2 , Figure 1 Figure 5 and Figure 6 ).
Transmission electron microscopy
The blank control group had normal CA1 hippocampal morphology, clear structure, and unchanged or- Finally, both CA2 and CA3 regions showed glial cell degeneration ( Figure 9 ).
The Xixin decoction group had slight CA1 hippocampal neuronal degeneration, dissolved and degenerated mitochondrial vesicles, and normal looking endoplasmic reticulum and Golgi apparatus. CA2 neurons had slight degeneration, the presence of neuronophagia, visible lipofuscin, and slight mitochondrial degeneration ( Figure 10 ).
Western blot
Aβ42: When compared with the Control group, mice in the Model group showed significantly increased levels of Aβ42 (P < 0.05). When compared with the Model group, Xixin decoction group had significantly decreased levels of Aβ42 (P < 0.05). Neither the Model nor the Aricept groups had significant differences in Aβ42 levels (P > 0.05). Finally, Aricept group compared to Xixin decoction group Aβ42 levels were significantly decreased (P < 0.05) ( Table 3 , Figure 11 and Figure 12 ). ture). Furthermore, there was evidence of expansion of both the endoplasmic reticulum and Golgi apparatus, visible lipofuscin, and myeloid bodies. Hippocampal CA2 neurons also showed serious cellular degeneration, visible cytoplasmic myeloid bodies, and lipofuscin. There was also slight axonal degeneration, incomplete membranes, and irregular nuclei. Hippocampal CA3 neurons addicted to neural phenomena, expansion of mitochondrial ridge bubbles, irregularly shaped neuronal nuclei, and lipofuscin ( Figure 8 ).
The Aricept group showed neuronal degeneration in the hippocampal CA1 region, including irregularly shaped nuclei and expansion of mitochondrial ridge bubbles. Both the endoplasmic reticulum and Golgi apparatus appeared to have normal morphology. Hippocampal CA2 and CA3 neurons showed significant mitochondrial swelling and a small amount of lipofuscin. 
Discussion
Aβ is thought to be a core factor in the pathogenesis the Model group showed a marked increase in was BACE fluorescence. When compared with the Model group, the Xixin decoction group showed a decrease in BACE fluorescence. When compared with the Model group, the Aricept group showed no notable differences in BACE fluorescence. When compared with the Aricept group, there was a marked decrease in BACE fluorescence in the Xixin decoction group (Figure 21, Figure 22 , Figure 23 and Figure 24 ).
IDE:
When compared with the Blank Control group, the Model group showed a markedly decreased IDE effects for many types of neurons, including cholinergic ones as well as those located in the hippocampus. Moreover, both can also affect synaptic plasticity [9] . Past work has shown that Aβ oligomers can affect the postsynaptic density as well as the dendritic spine [10] . Moreover, in vivo work has shown that Aβ oligomers can immediately disrupt the formation of LTP, leading to problems with memory formation [11] . BACE 1 is β secretase [12] , which is a primary, limiting enzyme that promotes the Aβ formation and causes age of AD and is sheared from β-amyloid precursor protein through the sequential actions of β and γ secretases [7] . Resulting Aβ fragments gather and form the final soluble oligomer, which has demonstrable neurotoxicity [8] . The oligomer mixture that is composed of Aβ42 can form a diffusible portion (ADDLS), which is its most toxic form. This neurovirulent substance is soluble and contains no fiber. Only a small amount of this substance can lead to damage of the mature neuron. Synaptic dysfunction and the oxidative stress response can produce various toxic pigment. Much research has shown that BACE 1 expression and enhancement of enzymatic activity are important molecular pathological characteristics for early phase AD. In current AD therapeutic research, the regulation of BACE 1 expression has been regarded as a major therapeutic target that could lead to efficient treatment effects [13, 14] .
IDE is a downstream, of metalloprotease insulin receptor that is expressed in all cells of the body. It is primarily localized in the cytoplasm, peroxisome and endosome and is predominantly expressed in the liver, muscles, and brain tissues. IDE typically functions as an extracellular receptor in the form of homocystein of thiolactone and as a dimer or trimer. In particular, the dimer form has high biological activities and can eliminate various peptide materials, including Aβ and insulin [15] . Furthermore, IDE can degrade Aβ under neutral conditions and prevent the formation of age pigment as well as eliminate Aβ neurotoxicity [16] . Aβ 42 -the major ingredient of age pigment-is a substrate that is known to be degraded by IDE. Given this, IDE can play an important role in the formation of AD by adjusting the levels of Aβ degradation.
Our experiment found that when compared with the Model group, mice treated with Xixin had significantly shorter escape latencies in a Morris water maze test (p < 0.05). Moreover, they also had a significant increase in the frequency of platform crossings (p < 0.05). When compared with the Model and Aricept groups, Xixin treated mice had marked decreases in hippocampal neuronal degeneration. When compared with the Model groups, Xixin treatment resulted in reduction of Aβ42 expression in specific brain areas (p < 0.05). Xixin treatment also resulted in a significant decrease to BACE expression (p < 0.05) with a significant increase in IDE expression (p < 0.05).
Collectively, these result showed that Xixin treatment resulted in improvements to learning and memory in APP double transgenic mice. Moreover, it also had a protective effect on hippocampal neurons as well as their synaptic construction and function. Xixin treatment also reduced Aβ42 content in brain tissue of APP double transgenic mice and restrained IDE overexpression. Given these, we speculate that the mechanism of Xixin in improving AD learning and memory capabilities and preventing AD pathological process are through inhibition of BACE. This inhibition leads to a reduction in Aβ generation and promotion of brain IDE expression. Ultimately, this leads to acceleration in the degradation and elimination of Aβ42, reaching a relative balance between the generation and elimination of Aβ in the brain. However, the mechanism behind the actions of Xixin in reliv-
